China is the second largest market for pharmaceuticals on the planet, behind the United States. In one of its first concessions to U.S. trade pressure, China has extended patent protection for drugs to 25 years, up from 20 years. The change brings China into line with the U.S. and Europe, which allow a drug maker extra […]
We previously described the evils of inter partes review, by which administrative panels within the USPTO kill issued patents with wild abandon. Former Chief Judge Rader of the Federal Circuit Court of Appeals described inter partes review panels as ‘death squads killing property rights.’ A constitutional challenge to inter partes review was recently decided by the […]
The distinctive smell of Play-Doh evokes memories of many happy hours of childhood play, those of my children and mine. Perhaps, if you played with the colored “doh,” you probably share similar nostalgia. Hasbro has been making Play-Doh since the 1950’s and its distinct odor is not natural but a fragrance that Hasboro added to […]
Dear Doc: I’m an AMERICAN. I run an AMERICAN business. I sell red hats that say “MAKE AMERICA GREAT AGAIN” I have an AMERICAN website. My customers are mostly proud AMERICANS. Now a bunch of FOREIGNERS from EUROPE are making rules about the information that I collect and the emails that I send. SAD! Can’t […]
If your company collects, controls or processes information that can be used to identify an individual resident of the EU, either directly or indirectly, then the EU considers that you are subject to the GDPR regardless of where your company is located. The identifying data may include, among other things, names, birthdates, addresses, e-mail and […]
In April 2016, the European Union (“EU”) enacted the General Data Protection Regulation (GDPR). You may ask, I’m a U.S. business so why should I care. It may be obvious but the United States is the EU’s largest trading partner. You may think that Europe is a far away place but any regulation that affects […]